Institute of Experimental Medicine: New biotechnologies, nanomaterials and stem cells for use in regenerative medicine

Institute of Experimental Medicine of the ASCR, v.v.i.
AV0Z50390703
New biotechnologies, nanomaterials and stem cells for use in regenerative medicine

The Research Plan will focus on the important modern field of regenerative medicine. We will develop techniques for using adult and embryonic stem cells, biomaterials, nanomaterials, new technologies and diagnostic methods. The major aim of the Plan is to find effective therapies for serious diseases, currently incurable, and to introduce them into practical use. The results will be used in: neurosurgery (artificial replacements, bridging of defects), traumatology (CNS injury), neurology (Parkinson's disease, multiple sclerosis), immunology (immune system diseases), pediatrics (inborn defects, perinatal injuries), orthopedics (bone and cartilage replacement), ophthalmology (corneal replacement), otolaryngology, stomatology (tooth replacements), anaplasty, dermatology, and others. We plan to develop products for clinical studies, treatment and business. The results will be used by the pharmaucetical industry to develop new diagnostic kits and drugs and to test them on stem cells.